Multiplex genotyping as a biomarker for susceptibility to carcinogenic exposure in the FLEHS biomonitoring study

Cancer Epidemiology Biomarkers and Prevention

Volumn 17, Issue 8, 2008, Pages 1902-1912

  Ketelslegers, Hans B ^a   Gottschalk, Ralph W H ^a   Koppen, Gudrun ^b   Schoeters, Greet ^b   Baeyens, Willy F ^c   Van Larebeke, Nicolas A ^d   Van Delft, Joost H M ^a   Kleinjans, Jos C S ^a  

^a MAASTRICHT UNIVERSITY   (Netherlands)

^b FLEMISH INSTITUTE FOR TECHNOLOGICAL RESEARCH VITO   (Belgium)

^c VRIJE UNIVERSITEIT BRUSSEL   (Belgium)

^d GHENT UNIVERSITY   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

1 HYDROXYPYRENE; 1,1 DICHLORO 2,2 BIS(4 CHLOROPHENYL)ETHANE; 8 HYDROXYDEOXYGUANOSINE; BIOLOGICAL MARKER; CADMIUM; CARCINOEMBRYONIC ANTIGEN; CARCINOGEN; HEXACHLOROBENZENE; LEAD; MUCONIC ACID; ORGANOCHLORINE DERIVATIVE; POLYCHLORINATED BIPHENYL; PROSTATE SPECIFIC ANTIGEN; PROTEIN P53; TUMOR MARKER;

ADOLESCENT; ADULT; ARTICLE; BIOLOGICAL MONITORING; BIOTRANSFORMATION; CANCER RISK; CANCER SUSCEPTIBILITY; CELL NUCLEUS; COMET ASSAY; DNA REPAIR; ENVIRONMENTAL EXPOSURE; ENVIRONMENTAL HEALTH; FEMALE; GENE FUNCTION; GENETIC POLYMORPHISM; GENETIC SELECTION; GENOTOXICITY; GENOTYPE; HEALTH SURVEY; HUMAN; LYMPHOCYTE; MALE; OXIDATIVE STRESS; PRIORITY JOURNAL;

ADOLESCENT; ADULT; AGED; BELGIUM; CARCINOGENS, ENVIRONMENTAL; DNA REPAIR; ENVIRONMENTAL MONITORING; EPIDEMIOLOGY, MOLECULAR; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; LOGISTIC MODELS; MALE; MIDDLE AGED; OXIDATIVE STRESS; POLYMERASE CHAIN REACTION; POLYMORPHISM, GENETIC; POPULATION SURVEILLANCE; QUESTIONNAIRES; SMOKING; STATISTICS, NONPARAMETRIC; TUMOR MARKERS, BIOLOGICAL;

EID: 54049083536     PISSN: 10559965     EISSN: None     Source Type: Journal    
DOI: 10.1158/1055-9965.EPI-08-0045     Document Type: Article

References (54)

1. Perera FP. Molecular epidemiology: insights into cancer susceptibility, risk assessment, and prevention. J Natl Cancer Inst 1996;88:496-509.
2. Perera FP, Weinstein IB. Molecular epidemiology and carcinogen-DNA adduct detection: new approaches to studies of human cancer causation. J Chronic Dis 1982;35:581-600.
3. Tharappel JC, Lee EY, Robertson LW, Spear BT, Glauert HP. Regulation of cell proliferation, apoptosis, and transcription factor activities during the promotion of liver carcinogenesis by polychlorinated biphenyls. Toxicol Appl Pharmacol 2002;179:172-84.
4. Safe SH. Polychlorinated biphenyls (PCBs): environmental impact, biochemical and toxic responses, and implications for risk assessment. Crit Rev Toxicol 1994;24:87-149.
5. Mariussen E, Fonnum F. Neurochemical targets and behavioral effects of organohalogen compounds: an update. Crit Rev Toxicol 2006;36:253-89.
6. Ezendam J, Vissers I, Bleumink R, Vos JG, Pieters R. Immunomodulatory effects of tetrachlorobenzoquinone, a reactive metabolite of hexachlorobenzene. Chem Res Toxicol 2003;16:688-94.
7. Valko M, Rhodes CJ, Moncol J, Izakovic M, Mazur M. Free radicals, metals and antioxidants in oxidative stress-induced cancer. Chem Biol Interact 2006;160:1-40.
8. Knaapen AM, Ketelslegers HB, Gottschalk RW, et al. Simultaneous genotyping of nine polymorphisms in xenobiotic-metabolizing enzymes by multiplex PCR amplification and single base extension. Clin Chem 2004;50:1664-8.
9. Gomara B, Ramos L, Gonzalez MJ. Determination of polychlorinated biphenyls in small-size serum samples by solid-phase extraction followed by gas chromatography with micro-electron-capture detection. J Chromatogr B Analyt Technol Biomed Life Sci 2002;766:279-87.
10. Covaci A, Schepens P. Simplified method for determination of organochlorine pollutants in human serum by solid-phase disk extraction and gas chromatography. Chemosphere 2001;43:439-47.
11. Angerer J, Schaller KH. Analysis of hazardous substances in biological materials. Wiley-VCH 1997;5:125-41.
12. Angerer J, Schaller KH. Analysis of hazardous substances in biological materials. Wiley-VCH 1998;6:170-87.
13. Singh NP, McCoy MT, Tice RR, Schneider EL. A simple technique for quantitation of low levels of DNA damage in individual cells. Exp Cell Res 1988;175:184-91.
14. Fenech M. The in vitro micronucleus technique. Mutat Res 2000;455:81-95.
15. Ketelslegers HB, Gottschalk RW, Godschalk RW, et al. Interindividual variations in DNA adduct levels assessed by analysis of multiple genetic polymorphisms in smokers. Cancer Epidemiol Biomarkers Prev 2006;15:624-9.
16. Midorikawa K, Uchida T, Okamoto Y, et al. Metabolic activation of carcinogenic ethylbenzene leads to oxidative DNA damage. Chem Biol Interact 2004;150:271-81.
17. Subrahmanyam VV, Kolachana P, Smith MT. Hydroxylation of phenol to hydroquinone catalyzed by a human myeloperoxidase-superoxide complex: possible implications in benzene-induced myelotoxicity. Free Radic Res Commun 1991;15:285-96.
18. Tuo J, Loft S, Thomsen MS, Poulsen HE. Benzene-induced genotoxicity in mice in vivo detected by the alkaline comet assay: reduction by CYP2E1 inhibition. Mutat Res 1996;368:213-9.
19. Tuo J, Deng X, Loft S, Poulsen HE. Dexamethasone ameliorates oxidative DNA damage induced by benzene and LPS in mouse bone marrow. Free Radic Res 1999;30:29-36.
20. Ahn J, Gammon MD, Santella RM, et al. Associations between breast cancer risk and the catalase genotype, fruit and vegetable consumption, and supplement use. Am J Epidemiol 2005;162:943-52.
21. Hayes JD, Strange RC. Glutathione S-transferase polymorphisms and their biological consequences. Pharmacology 2000;61:154-66.
22. Hong YC, Park HS, Ha EH. Influence of genetic susceptibility on the urinary excretion of 8-hydroxydeoxyguanosine of firefighters. Occup Environ Med 2000;57:370-5.
23. Loft S, Vistisen K, Ewertz M, et al. Oxidative DNA damage estimated by 8-hydroxydeoxyguanosine excretion in humans: influence of smoking, gender and body mass index. Carcinogenesis 1992;13:2241-7.
24. Kim YD, Lee CH, Nan HM, Kang JW, Kim H. Effects of genetic polymorphisms in metabolic enzymes on the relationships between 8-hydroxydeoxyguanosine levels in human leukocytes and urinary 1-hydroxypyrene and 2-naphthol concentrations. J Occup Health 2003;45:160-7.
25. Pavanello S, Clonfero E. [Individual susceptibility to occupational carcinogens: the evidence from biomonitoring and molecular epidemiology studies]. G Ital Med Lav Ergon 2004;26:311-21.
26. Perera FP. Environment and cancer: who are susceptible? Science 1997;278:1068-73.
27. Nerurkar PV, Okinaka L, Aoki C, et al. CYP1A1, GSTM1, and GSTP1 genetic polymorphisms and urinary 1-hydroxypyrene excretion in non-occupationally exposed individuals. Cancer Epidemiol Biomarkers Prev 2000;9:1119-22.
28. Cascorbi I, Brockmoller J, Roots I. A C4887A polymorphism in exon 7 of human CYP1A1: population frequency, mutation linkages, and impact on lung cancer susceptibility. Cancer Res 1996;56:4965-9.
29. Spurr NK, Gough AC, Stevenson K, Wolf CR. Msp-1 polymorphism detected with a cDNA probe for the P-450 I family on chromosome 15. Nucleic Acids Res 1987;15:5901.
30. Crofts F, Cosma GN, Currie D, et al. A novel CYP1A1 gene polymorphism in African-Americans. Carcinogenesis 1993;14:1729-31.
31. Hayashi S, Watanabe J, Nakachi K, Kawajiri K. Genetic linkage of lung cancer-associated MspI polymorphisms with amino acid replacement in the heme binding region of the human cytochrome P450IA1 gene. J Biochem (Tokyo) 1991;110:407-11.
32. Loft S, Poulsen HE. Cancer risk and oxidative DNA damage in man. J Mol Med 1996;74:297-312.
33. Georgiadis P, Demopoulos NA, Topinka J, et al. Impact of phase I or phase II enzyme polymorphisms on lymphocyte DNA adducts in subjects exposed to urban air pollution and environmental tobacco smoke. Toxicol Lett 2004;149:269-80.
34. Hassett C, Robinson KB, Beck NB, Omiecinski CJ. The human microsomal epoxide hydrolase gene (EPHX1): complete nucleotide sequence and structural characterization. Genomics 1994;23:433-42.
35. Sala M, Sunyer J, Otero R, et al. Health effects of chronic high exposure to hexachlorobenzene in a general population sample. Arch Environ Health 1999;54:102-9.
36. Canonero R, Campart GB, Mattioli F, Robbiano L, Martelli A. Testing of p-dichlorobenzene and hexachlorobenzene for their ability to induce DNA damage and micronucleus formation in primary cultures of rat and human hepatocytes. Mutagenesis 1997;12:35-9.
37. Kawajiri K, Watanabe J, Hayashi S. Identification of allelic variants of the human CYP1A1 gene. Methods Enzymol 1996;272:226-32.
38. Li YF, Shi N, Li HY, et al. [Toxicity and oxidative stress on rats by hexachlorobenzene]. Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi 2006;24:601-4.
39. Iscan M, Coban T, Cok I, et al. The organochlorine pesticide residues and antioxidant enzyme activities in human breast tumors: is there any association? Breast Cancer Res Treat 2002;72:173-82.
40. Bertin G, Averbeck D. Cadmium: cellular effects, modifications of biomolecules, modulation of DNA repair and genotoxic consequences (a review). Biochimie 2006;88:1549-59.
41. IARC. Some industrial chemicals and dyestuffs. IARC monographs on the evaluation of the carcinogenic risk of chemicals to humans. IARC (Lyon) 1982;29:93-148.
42. Price DJ, Joshi JG. Ferritin. Binding of beryllium and other divalent metal ions. J Biol Chem 1983;258:10873-80.
43. Casalino E, Sblano C, Landriscina C. Enzyme activity alteration by cadmium administration to rats: the possibility of iron involvement in lipid peroxidation. Arch Biochem Biophys 1997;346:171-9.
44. McMurray CT, Tainer JA. Cancer, cadmium and genome integrity. Nat Genet 2003;34:239-41.
45. Mikhailova MV, Littlefield NA, Hass BS, Poirier LA, Chou MW. Cadmium-induced 8-hydroxydeoxyguanosine formation, DNA strand breaks and antioxidant enzyme activities in lymphoblastoid cells. Cancer Lett 1997;115:141-8.
46. Xie J, Shaikh ZA. Cadmium induces cell cycle arrest in rat kidney epithelial cells in G2/M phase. Toxicology 2006;224:56-65.
47. Polyak K, Xia Y, Zweier JL, Kinzler KW, Vogelstein B. A model for p53-induced apoptosis. Nature 1997;389:300-5.
48. Badawi AF. Molecular and genetic events in schistosomiasis-associated human bladder cancer: role of oncogenes and tumor suppressor genes. Cancer Lett 1996;105:123-38.
49. Collins AR. Molecular epidemiology in cancer research. Mol Aspects Med 1998;19:359-432.
50. Steinmetz-Beck A, Szahidewicz-Krupska E, Beck B, Poreba R, Andrzejak R. [Genotoxicity effect of chronic lead exposure assessed using the comet assay]. Med Pr 2005;56:295-302.
51. Karakaya AE, Ozcagli E, Ertas N, Sardas S. Assessment of abnormal DNA repair responses and genotoxic effects in lead exposed workers. Am J Ind Med 2005;47:358-63.
52. Danadevi K, Rozati R, Saleha Banu B, Hanumanth Rao P, Grover P. DNA damage in workers exposed to lead using comet assay. Toxicology 2003;187:183-93.
53. van Larebeke N, Husson B, De Coen W, Pluygers E. Immunologic and other biological parameters as a function of smoking status and of residence in areas differing in terms of air pollution. Int J Environ Health Res 2003;13:55-69.
54. Rothman KJ. No adjustments are needed for multiple comparisons. Epidemiology 1990;1:43-6.